NUWE
Nuwellis IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$2.85M
P/E Ratio
—
EPS
$-25.39
Beta
0.08
52W High
$45.36
52W Low
$0.96
50-Day MA
$1.86
200-Day MA
$4.12
Dividend Yield
—
Profit Margin
-211.90%
Forward P/E
—
PEG Ratio
—
About Nuwellis Inc
Nuwellis, Inc., a medical device company, focuses on the development, manufacture and marketing of medical devices used in ultrafiltration therapy. The company is headquartered in Eden Prairie, Minnesota.
Fundamentals
| Revenue (TTM) | $8.27M |
| Gross Profit (TTM) | $5.12M |
| EBITDA | $-10.91M |
| Operating Margin | -100.80% |
| Return on Equity | -382.50% |
| Return on Assets | -86.90% |
| Revenue/Share (TTM) | $11.98 |
| Book Value | $1.56 |
| Price-to-Book | 0.96 |
| Price-to-Sales (TTM) | 0.34 |
| EV/Revenue | 0.214 |
| EV/EBITDA | -0.34 |
| Quarterly Earnings Growth (YoY) | -99.20% |
| Quarterly Revenue Growth (YoY) | 4.40% |
| Shares Outstanding | $2.64M |
| Float | $2.28M |
| % Insiders | 1.00% |
| % Institutions | 5.17% |
Analyst Ratings
Consensus ($11.00 target)
1
HoldData last updated: 4/9/2026